News

Banks are among the biggest risers on UK’s green light for Oxford-AstraZeneca vaccine

Lenders bounce back after post-Christmas fall as new inoculation is approved

The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December
The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December Photo: Barry Lewis/Getty Images

Banking stocks were among the top climbers on the FTSE 100, which rose on 30 December on the back of the UK government’s approval of the Oxford-AstraZeneca coronavirus vaccine.

Pricing in the news of the vaccine saw an uptick across the banks including NatWest (+2.75%), Lloyds Banking Group (+2.24%), Standard Chartered (+2.03%), HSBC (+1.64%) and Barclays (+1.47%), along with financial services firms like Legal & General (1.81%).

WSJ Logo
Jamie Dimon Says Private Credit Is Dangerous—and He Wants JPMorgan to Get In on ItExternal link

Jamie Dimon Says Private Credit Is Dangerous—and He Wants JPMorgan to Get In on It